Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Sickle Cell Disease (SCD)
In brief
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sickle cell disease (SCD) patients with history of vaso-occlusive crisis (VOC) leading to healthcare visit.
Key facts
- Study ID
- NCT03814746
- Run by
- Novartis Pharmaceuticals
- People needed
- 255
- Starts
- 2019-07-26
- Expected to finish
- 2026-11-23
- Last updated by the study team
- 2026-07-10
Who can join
Age: 12 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Boston Medical Center — Boston, Massachusetts, United States
- Levine Cancer Insitute Carolinas Healthcare System — Charlotte, North Carolina, United States
- Univ of Tenn Health Sciences Ctr — Memphis, Tennessee, United States
- U of TX Health Science Ct — Houston, Texas, United States
- Novartis Investigative Site — Brussels, Brussels Capital, Belgium
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Edegem, Belgium
- Novartis Investigative Site — Salvador, Estado de Bahia, Brazil
- Novartis Investigative Site — Belém, Pará, Brazil
- Novartis Investigative Site — Recife, Pernambuco, Brazil
- Novartis Investigative Site — Rio de Janeiro, Rio de Janeiro, Brazil
- Novartis Investigative Site — Porto Alegre, Rio Grande do Sul, Brazil
- Novartis Investigative Site — Ribeirão Preto, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — Toronto, Ontario, Canada
- Novartis Investigative Site — Montreal, Quebec, Canada
- Novartis Investigative Site — Barranquilla, Atlántico, Colombia
- Novartis Investigative Site — Valledupar, Cesar Department, Colombia
- Novartis Investigative Site — Montería, Colombia
- Novartis Investigative Site — Helsinki, Finland
- Novartis Investigative Site — Créteil, France
- Novartis Investigative Site — Marseille, France
- Childrens Healthcare of Atlanta — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.